StockData
Cogent Biosciences, Inc. logo

Cogent Biosciences, Inc. (COGT) stock

COGTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 2/30
$27.81−0.04 (-0.14%)

Close on Nov 18, 2026Market cap $4.83BP/E –Yield –

Cogent Biosciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Cogent Biosciences's price to sales ratio was 35.7× on Apr 30, 2021, against 0.6× a year earlier. Over the last 3 years it ranged from 0.5× to 58.4×, with a median of 7.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2021Apr 30, 202135.7×+30.5
2020Dec 31, 20205.2×+3.2
2019Dec 31, 20192.0×−14.3
2018Dec 31, 201816.4×–

More Cogent Biosciences figures

See a number that looks wrong?